Suchergebnisse - "Chu, Helen Y"

PubPharm (7)

1

Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infection

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2023

von Guenthoer, J. | Lilly, M. | Starr, T. | +13

UpdateOf: bioRxiv. 2023 Mar 29;:. - PMID 36561191

2

Receptor-Binding Domain (RBD) Antibodies Contribute More to SARS-CoV-2 Neutralization When Target Cells Express High Levels of ACE2

enthalten in: Viruses | 2022

von Farrell, A. | Dadonaite, B. | Greaney, A. | +9

UpdateOf: bioRxiv. 2022 Aug 30;:. - PMID 36093349

3

A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy

enthalten in: PLoS pathogens | 2022

von Greaney, A. | Starr, T. | Eguia, R. | +11

UpdateOf: bioRxiv. 2021 Oct 13;:. - PMID 34671768

4

Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects

enthalten in: Cell reports | 2021

von Jennewein, M. | MacCamy, A. | Akins, N. | +26

UpdateOf: bioRxiv. 2021 Mar 24;:. - PMID 33791692

5

Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies

enthalten in: Cell host & microbe | 2021

von Loes, A. | Crawford, K. | Starr, T. | +3

6

Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein

enthalten in: Nature medicine | 2020

von Zost, S. | Gilchuk, P. | Chen, R. | +28

UpdateOf: bioRxiv. 2020 May 13;:. - PMID 32511414

7

Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation

enthalten in: Immunity | 2020

von Seydoux, E. | Homad, L. | MacCamy, A. | +17

UpdateOf: bioRxiv. 2020 May 12;:. - PMID 32511342

1
[1]